Lithium Ion

Lithium Ion

SCHEMBL8563402

[Li+].[S-]c1cccs1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27261872 0.65
Lithium SCHEMBL31489997 0.62
SCHEMBL7227898 0.62 L3MBTL1 (0.50)
SCHEMBL16291133 0.62 L3MBTL1 (0.57)
SCHEMBL3545 0.62 L3MBTL1 (0.57)
Lithium Ion SCHEMBL9482149 0.61 FBP1 (0.38)
SCHEMBL6280818 0.61 KDM4E (0.48)
Lithium Ion SCHEMBL8749265 0.61 FBP1 (0.38)
Lithium Ion SCHEMBL8823607 0.61 FBP1 (0.38)
Fluoride SCHEMBL491501 0.60 L3MBTL1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0824532-A1 SYNTHESIS OF (S)-3-(2-THIENYLTHIO) BUTYRIC ACID AND ANALOGS Merck & Co., Inc. (US) 1998-02-25 EP disclosed
US-5574176-A Synthesis of an intermediate for the preparation of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno [2,3-b]thiopyran-2-sulfonamide 7,7-dioxide intermediates and related compounds MERCK & CO., INC. (US) 1996-11-12 US disclosed
WO-1996033990-A1 SYNTHESIS OF (S)-3-(2-THIENYLTHIO) BUTYRIC ACID AND ANALOGS MERCK & CO., INC. (US) 1996-10-31 WO disclosed